Keri Dufault has extensive work experience in the field of business development and marketing. Keri is currently working at Nitto Avecia as the Director of Business Development, a position they have held since October 2021. Prior to this role, they served as the Senior Business Development and Marketing Manager from April 2020 until their promotion. Keri also held the position of Senior Business Development Manager from July 2019 to April 2020, and worked as a Business Development Manager from April 2017 to July 2019. Previously, Keri was a Business Development Associate at Nitto Avecia from April 2016 to April 2017. Before joining Nitto Avecia, they worked at Nitto Denko Avecia as a Manufacturing Project Support Specialist from November 2010 to January 2015. Prior to that, they were a research associate at Alnylam Pharmaceuticals from October 2008 to October 2010. Keri began their career as a Process Chemist III at Avecia from August 2006 to October 2008.
Keri Dufault attended Saint Anselm College from 2002 to 2006, but no information is available regarding the degree obtained or field of study pursued during this period.
Org chart
Teams
This person is not in any teams
Offices
Nitto Avecia
1 followers
Oligonucleotides are giving rise to a new generation of therapeutics—and Nitto Avecia is helping lead the way. With more than 25 years’ experience in oligonucleotide development and production, we are the partner of choice for pharmaceutical innovators creating new drugs with the power to transform treatment for a wide range of diseases. In partnership with Nitto Avecia Pharma Services, Nitto Avecia is the first CMO that offers a comprehensive, end-to-end oligonucleotide solution. This offers the advantage of a single, expert partner handling the entire process—from drug substance through drug product manufacturing—with flexible solutions and consistent reliability and quality.
